Quizartinib
Quizartinib (AC220) is an orally active, highly selective and potent second-generation type II FLT3 tyrosine kinase inhibitor, with a Kd of 1.6 nM. Quizartinib inhibits wild-type FLT3 and FLT3-ITD autophosphorylation in MV4-11 cells with IC50s of 4.2 and 1.1 nM, respectively. Quizartinib can be linked to the VHL ligand via an optimized linker to form a PROTAC FLT3 degrader. Quizartinib induces apoptosis[1].
Product Specifications
CAS Number
950769-58-1
Product Name Alternative
AC220; AC708
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; FLT3; Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
Apoptosis; PROTAC; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Quizartinib.html
Purity
99.08
Solubility
DMF : 10 mg/mL (ultrasonic) |DMSO : ≥ 33 mg/mL
Smiles
O=C(NC1=NOC(C(C)(C)C)=C1)NC2=CC=C(C=C2)C3=CN4C(SC5=CC(OCCN6CCOCC6)=CC=C45)=N3
Molecular Formula
C29H32N6O4S
Molecular Weight
560.67
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (Fn-3), CF640R conjugate, 0.1mg/mL
CD35 / CR1 (E11), CF568 conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-51), CF740 conjugate, 0.1mg/mL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF405S conjugate, 0.1mg/mL
